Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose

Sleep Medicine

Volumn 14, Issue 11, 2013, Pages 1100-1104

  Grim, Kendra ^a   Lee, Bernard ^a   Sung, Alan Y ^a   Kotagal, Suresh ^a  

^a MAYO CLINIC   (United States)

Author keywords

Childhood; Iron sucrose; Periodic limb movement disorder; Restless legs syndrome; Serum ferritin

Indexed keywords

FERRITIN; IRON; IRON SACCHARATE;

ABDOMINAL DISCOMFORT; ADOLESCENT; ANAPHYLAXIS; ANOREXIA; ARTICLE; CHILD; CLINICAL ARTICLE; COMORBIDITY; CONSTIPATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRON DEFICIENCY; IRON THERAPY; MALE; MEDICAL RECORD REVIEW; MUSCULOSKELETAL SYSTEM PARAMETERS; NAUSEA; ONSET AGE; OUTCOME ASSESSMENT; PERIODIC LIMB MOVEMENT DISORDER; PERIODIC LIMB MOVEMENT INDEX; POLYSOMNOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DETERMINATION; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDY; SCHOOL CHILD; SLEEP DISORDER; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VOMITING;

CHILDHOOD; IRON SUCROSE; PERIODIC LIMB MOVEMENT DISORDER; RESTLESS LEGS SYNDROME; SERUM FERRITIN;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; FEMALE; FERRIC COMPOUNDS; FERRITINS; GLUCARIC ACID; HEMATINICS; HUMANS; MALE; NOCTURNAL MYOCLONUS SYNDROME; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDIES;

EID: 84886782220     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2013.06.006     Document Type: Article

References (25)

1. Picchietti D., Allen R.P., Walters A.S., Davidson J.E., Myers A., Ferini-Strambi I. Restless legs syndrome: prevalence and impact in children and adolescents - the Peds REST study. Pediatrics 2007, 120:253-266.
2. Kotagal S., Silber M.H. Childhood-onset restless legs syndrome. Ann Neurol 2004, 56:803-807.
3. Walters A.S., Silvestri R., Zucconi M., Chandrashekariah R., Konofal E. Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders. J Clin Sleep Med 2008, 4:591-600.
4. Picchietti D.L., Underwood D.J., Farris W.A., Walters A.S., Shah M.M., Dahl R.E., et al. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention deficit hyperactivity disorder. Mov Disord 1999, 14:1000-1007.
5. Abetz I., Allen R., Washburn T., Early C. The impact of restless legs syndrome (RLS) on sleep and cognitive function. Eur J Neurol 2004, 9(Suppl. 2):S50.
6. Picchietti M.A., Picchietti D.L. Advances in pediatric restless legs syndrome: Iron, genetics, diagnosis and treatment. Sleep Med 2010, 11:643-651.
7. Picchietti D.L., Stevens H.E. Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med 2008, 9:770-781.
8. Winkelman J.W. Periodic limb movements in sleep-endophenotype for restless legs syndrome?. N Engl J Med 2007, 357:703-705.
9. Picchietti D.L., Rajendran R.R., Wilson M.P., Picchietti M.A. Pediatric restless legs syndrome and periodic limb movement disorder: parent-child pairs. Sleep Med 2009, 10:925-931.
10. Picchietti D., Stevens H.E. Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med 2008, 9:770-781.
11. Wang J., O'Reilly B., Venkatraman R., Mysliwieck V., Mysliwieck A. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritn: a randomized, double blind, placebo-controlled study. Sleep Med 2009, 10:973-975.
12. Kryger M.H., Otake K., Foerster J. Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers. Sleep Med 2002, 3:127-132.
13. Mohri I., Kato-Nishimura K., Kagitani-Shimono K., Kimura-Ohba S., Ozono K., Tachibana N., et al. Evaluation of oral iron treatment in pediatric restless legs syndrome. Sleep Med 2012, 13:429-432.
14. Simakajornboon N., Gozal D., Vlasic V., Mack C., Sharon D., McGinley B.M. Periodic limb movements in sleep and iron status in children. Sleep 2003, 26:735-738.
15. Pinsk V., Levy J., Moser A., Yerushlami B., Kapelushnik J. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency. Isr Med Assoc J 2008, 10:335-338.
16. Ondo W.G. Intravenous iron dextran for severe, refractory restless legs syndrome. Sleep Med 2010, 11:494-496.
17. Cho Y.W., Allen R.P., Earley C.J. Lower molecular weight iron dextran for restless legs syndrome. Sleep Med 2013, 14:274-277.
18. Allen R.P., Adler C.H., Du W., Butcher A., Bergman D.B., Earley C.J. Clinical safety and efficacy of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centered, placebo-controlled preliminary clinical trial. Sleep Med 2011, 12:906-913.
19. Auerbach M. Clinical update: intravenous iron for anemia 2007, 369:1502-1504.
20. Earley C.J., Horska A., Mohamed M.A., Barker P.B., Beard J.L., Allen R.P. A randomized, double blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009, 10:206-211.
21. Grote L., Leissner L., Hedner J., Ulfberg J. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord 2009, 24:1445-1452.
22. Anbu A.T., Kemp T., O'Donnell K., Smith P.A., Bradbury M.G. Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose infusions in children on erythropoietin. Acta Pediatr 2005, 94:1738-1744.
23. Allen R.P., Picchietti D.L., Hening W.A., Trenkwalder C., Walters A.S., Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4:101-119.
24. Wysowski D.K., Swartz L., Borders-Hemphill B.V., Goulding M.R., Dormitzer C. Use of parenteral iron products and serious anaphylactic-type reactions. Am J Hematol 2010, 85:650-654.
25. Auerbach M., Al Talib K. Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. Kidney Int 2008, 73:528-530.